SAMANTHA BARROW: Open Payments
NPI 1275290017 · ROCHESTER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 54 payments from 21 companies in 2025. Trend: 2023 $570 · 2024 $997 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| PFIZER INC. | 7 | $112 |
| Novo Nordisk Inc | 6 | $95 |
| Amgen Inc. | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Astellas Pharma US Inc | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| ABBVIE INC. | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
Products named: AIRSUPRA, NURTEC ODT, BREZTRI, Auvelity, Veozah, Wegovy, CAPLYTA, REXULTI.
Industry payments across MI — which companies pay providers there.
